ecancermedicalscience

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Enrique Soto Pérez de Celis MD, PhD, FASCO

ISSN: 1754-6605

Submit article

1699-smoking-cessation-counselling-patterns-in-cancer-patients-survey-of-lebanese-physicians

Research: Smoking cessation counselling patterns in cancer patients – survey of Lebanese physicians

Jad Najdi, Mariana El Hawa, Adnan El-Achkar, Nour Naji, Talar Telvizian, Maya Romani, Albert El Hajj, Deborah Mukherji

25 Apr 2024

https://doi.org/10.3332/ecancer.2024.1699

Abstract | Full Article | PDF

1663-survival-rate-of-cervical-cancer-a-five-year-review-at-a-major-teaching-hospital-in-ghana-west-africa

Research: Survival rate of cervical cancer: a five year review at a Major Teaching Hospital in Ghana, West Africa

Joseph Daniels, Kwesi Asante, Judith Naa Odey Tackie, Kofi Adesi Kyei

1 Feb 2024

https://doi.org/10.3332/ecancer.2024.1663

Abstract | Full Article | PDF

1644-re-challenge-of-immune-checkpoint-inhibitor-pembrolizumab-with-concurrent-tocilizumab-after-prior-grade-3-pneumonitis

Case Report: Re-challenge of immune checkpoint inhibitor pembrolizumab with concurrent tocilizumab after prior grade 3 pneumonitis

Chitrakshi Nagpal, Sameer Rastogi, Shamim A Shamim, Sneha Prakash

8 Dec 2023

https://doi.org/10.3332/ecancer.2023.1644

Abstract | Full Article | PDF

1639-young-filipino-breast-cancer-patients-have-worse-survival-outcomes

Research: Young Filipino breast cancer patients have worse survival outcomes

Ralph Victor Yap, Deanne Lou Marquez, Frances Marion De La Serna

23 Nov 2023

https://doi.org/10.3332/ecancer.2023.1639

Abstract | Full Article | PDF

1638-activity-of-capecitabine-for-central-nervous-system-metastases-from-breast-cancer

Research: Activity of capecitabine for central nervous system metastases from breast cancer

Mariana Carvalho Gouveia, Cassio Murilo Hidalgo Filho, Raquel Andrade Moreno, Heitor Castelo Branco Rodrigues Alves, Aline Sgnolf Ayres, Laura Testa, Renata Colombo Bonadio

23 Nov 2023

https://doi.org/10.3332/ecancer.2023.1638

Abstract | Full Article | PDF

1634-lucia-15-a-real-world-prospective-study-of-parp-inhibitors-for-the-treatment-of-patients-with-her-2-negative-metastatic-breast-cancer-with-germline-and-or-somatic-mutation-of-brca-genes-or-homologous-recombination-repair-related-genes

Special Issue: LuciA-15 – a real-world prospective study of PARP inhibitors for the treatment of patients with HER-2 negative metastatic breast cancer with germline and/or somatic mutation of BRCA genes or homologous recombination repair related genes

Fernando E Petracci, Cynthia Villarreal-Garza, Facundo Argañaraz, Gonzalo Gomez Abuin, José Peñaloza, Marcos Ariel Flores, Luciano Piazzoni, Cecilia Riggi, Lucía Fabiano, Lucía González, Belén Cieplinski, Sergio Rivero, Ernesto Korbenfeld, Pablo Mandó

21 Nov 2023

https://doi.org/10.3332/ecancer.2023.1634

Abstract | Full Article | PDF

1625-biochemical-outcome-after-curative-treatment-for-localized-prostate-cancer-with-external-beam-radiotherapy-a-cross-sectional-study

Research: Biochemical outcome after curative treatment for localized prostate cancer with external beam radiotherapy: a cross-sectional study

Joseph Daniels, Kofi Adesi Kyei, Kikelomo Adeola Badejoko–Okunade, Samuel Anim-Sampong, Samuel Nii Adu Tagoe, William Kwadwo Antwi, Joana Ainuson-Quampah, Adewumi Alabi, Anthonia Sowunmi, Judith Naa Odey Tackie

10 Nov 2023

https://doi.org/10.3332/ecancer.2023.1625

Abstract | Full Article | PDF

1618-the-occurrence-and-risk-factors-of-chemotherapy-induced-neutropenia-in-patients-with-breast-cancer-not-receiving-primary-g-csf-prophylaxis

Research: The occurrence and risk factors of chemotherapy-induced neutropenia in patients with breast cancer not receiving primary G-CSF prophylaxis

Susanna Hilda Hutajulu, Siswi Oktariani, Agus Jati Sunggoro, Bagas Suryo Bintoro, Yufi Kartika Astari, Juan Adrian Wiranata, Irianiwati Widodo, Anita Ekowati, Mardiah Suci Hardianti, Kartika Widayati Taroeno-Hariadi, Johan Kurnianda, Ibnu Purwanto

2 Nov 2023

https://doi.org/10.3332/ecancer.2023.1618

Abstract | Full Article | PDF